888 studies found for:    Open Studies | "Prostatic Diseases"
Show Display Options
Rank Status Study
21 Recruiting Pilot Study of 18F-DCFPyL PET/CT in the Evaluation of Men With an Elevated PSA Following Radical Prostatectomy
Condition: Adenocarcinoma of the Prostate
Intervention: Drug: 18F-DCFPyL
22 Recruiting Enzalutamide and Cabazitaxel in Treating Patients With Metastatic, Hormone-Resistant Prostate Cancer
Conditions: Hormone-Resistant Prostate Cancer;   Metastatic Prostate Carcinoma;   Recurrent Prostate Carcinoma;   Stage IV Prostate Cancer
Interventions: Drug: Cabazitaxel;   Drug: Enzalutamide;   Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study;   Drug: Prednisone
23 Not yet recruiting Treatment Patterns in Castrate Resistant Prostate Cancer Patients With Bone Metastases in a Medicare Population
Condition: Prostate Cancer
Intervention: Drug: Xofigo (Radium-223 dichloride, BAY88-8223)
24 Not yet recruiting Linear Source Registry for Prostate Cancer
Condition: Prostate Cancer
Intervention: Radiation: Linear LDR Source
25 Not yet recruiting Docetaxel With or Without Ascorbic Acid in Treating Patients With Metastatic Prostate Cancer
Conditions: Hormone-Resistant Prostate Cancer;   Metastatic Prostate Carcinoma;   Stage IV Prostate Cancer
Interventions: Dietary Supplement: Ascorbic Acid;   Drug: Docetaxel;   Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study;   Other: Placebo;   Other: Quality-of-Life Assessment
26 Recruiting Trans-MAPP Symptom Patterns Study (SPS)
Conditions: Interstitial Cystitis;   Chronic Prostatitis
Intervention:
27 Recruiting Trial to Evaluate Safety and Immunogenicity of INO-5150 Alone or With INO-9012 in Men With Prostate Cancer
Condition: Prostate Cancer
Interventions: Biological: 2mg INO-5150;   Biological: 8.5mg INO-5150;   Biological: 2mg INO-5150 plus 1mg INO-9012;   Biological: 8.5mg INO-5150 plus 1mg INO-9012;   Device: Electroporation using CELLECTRA®-5P
28 Recruiting Study of the Effect of Chemotherapy With Cabazitaxel on Prostate Cancer
Condition: Bone Metastatic Prostate Cancer
Intervention: Drug: Cabazitaxel
29 Recruiting Towards Optimal Prescription of Chemotherapy in Prostate Cancer
Condition: Prostate Cancer
Intervention:
30 Not yet recruiting Metformin And Longevity
Condition: Prostate Cancer
Interventions: Drug: Metformin;   Radiation: PET-MRI Scan;   Drug: Placebo
31 Not yet recruiting Safety and Efficacy of OCL 503 in Prostate Artery Embolization
Conditions: Benign Prostatic Hyperplasia;   Benign Prostatic Hypertrophy
Intervention: Device: Prostate artery embolization.
32 Not yet recruiting Bioavailability Study of Fixed Dose Combination (FDC) Dutasteride and Tamsulosin Hydrochloride (HCl) Relative to One Dutasteride and One Tamsulosin HCl Tablet in Healthy Male Subjects
Condition: Prostatic Hyperplasia
Interventions: Drug: FDC capsule of dutasteride and tamsulosin;   Drug: Dutasteride soft gelatine capsule and tamsulosin HCl oral disintegrating tablet
33 Not yet recruiting Trial of Radiotherapy With Leuprolide and Enzalutamide in High Risk Prostate
Conditions: Prostatic Neoplasms;   Pelvic Nodal
Interventions: Drug: Enzalutamide;   Drug: Leuprolide
34 Not yet recruiting Open Label Phase Two Study of Enzalutamide With Concurrent Administration of Radium Ra 223 Dichloride in Castration-Resistant (Hormone-Refractory) Prostate Cancer Subjects With Symptomatic Bone Metastasis
Condition: Prostate Carcinoma Metastatic to the Bone
Interventions: Drug: Enzalutamide;   Radiation: Radium ra 223 dichloride
35 Recruiting Monitoring and Mapping of Erectile Nerve During RALP (MMEN Study)
Condition: Prostate Cancer
Intervention: Device: NIM-Eclipse
36 Not yet recruiting Pivotal Study to Assess the Safety and Effectiveness of the iTIND Device
Condition: Benign Prostate Hyperplasia
Interventions: Device: iTIND;   Procedure: Sham Arm
37 Not yet recruiting Neoadjuvant PROSTVAC-VF With or Without Ipilimumab for Prostate Cancer
Condition: Prostatic Neoplasms
Interventions: Biological: PROSTVAC V/F;   Drug: Ipilimumab
38 Not yet recruiting Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue (WATER)
Condition: Benign Prostatic Hyperplasia (BPH)
Interventions: Device: Aquablation;   Procedure: Transurethral Resection of the Prostate (TURP)
39 Recruiting Prostate Cancer E-Health-Tutorial
Condition: Prostate Cancer
Intervention: Other: Online tutorial
40 Recruiting Phase 1 Study of GEN0101 in Patients With Recurrence of CRPC
Condition: Castration Resistant Prostate Cancer
Intervention: Drug: GEN0101

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years